BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 811542)

  • 1. The effect of reduction and reoxidation on the biological activities and structure of human Clq (first component of complement).
    Heusser CH; Boesman M; Knobel HR; Jacot-Guillarmod H; Isliker H
    Immunochemistry; 1975 Mar; 12(3):213-9. PubMed ID: 811542
    [No Abstract]   [Full Text] [Related]  

  • 2. Cleavage products of C4b produced by enzymes in human serum.
    Shiraishi S; Stroud RM
    Immunochemistry; 1975 Dec; 12(12):935-9. PubMed ID: 815169
    [No Abstract]   [Full Text] [Related]  

  • 3. Structural studies on human Clq: non-covalent and covalent subunits.
    Yonemasu K; Stroud RM
    Immunochemistry; 1972 May; 9(5):545-54. PubMed ID: 4113858
    [No Abstract]   [Full Text] [Related]  

  • 4. Fc fragment of human immunoglobulin G: reduction and carboxymethylation of inter-chain disulfide bonds enhances complement activating capacity.
    Lopez de Castro JA; Vivanco F; Ortiz F
    Biochem Biophys Res Commun; 1977 Oct; 78(4):1319-26. PubMed ID: 921779
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitation of immune complexes by competitive inhibition of binding of Clq to insoluble IgG aggregates.
    Fletcher DS; Lin TY
    J Immunol Methods; 1977; 15(1):39-45. PubMed ID: 845441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of C-reactive protein with the first component of human complement.
    Claus DR; Siegel J; Petras K; Osmand AP; Gewurz H
    J Immunol; 1977 Jul; 119(1):187-92. PubMed ID: 17637
    [No Abstract]   [Full Text] [Related]  

  • 7. The structure and mechanism of activation of the first component of complement.
    Reid KB; Porter RR
    Contemp Top Mol Immunol; 1975; 4():1-22. PubMed ID: 1104255
    [No Abstract]   [Full Text] [Related]  

  • 8. The inactivator of the first component of human complement (C1INA). The complex formation with the activated first component of human complement (C1) or with its subcomponents.
    Nagaki K; Iida K; Inai S
    Int Arch Allergy Appl Immunol; 1974; 46(6):935-48. PubMed ID: 4210434
    [No Abstract]   [Full Text] [Related]  

  • 9. Clq production and secretion by fibroblasts.
    Al-Adnani MS; McGee JO
    Nature; 1976 Sep; 263(5573):145-6. PubMed ID: 967248
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.
    Zubler RH; Lange G; Lambert PH; Miescher PA
    J Immunol; 1976 Jan; 116(1):232-5. PubMed ID: 1245740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic digestion of the first component of human complement (C1q).
    Knobel HR; Heusser C; Rodrick ML; Isliker H
    J Immunol; 1974 Jun; 112(6):2094-101. PubMed ID: 4363509
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alternate complement pathway in Behçet disease (author's transl)].
    Kogure M; Ono Y
    Nippon Ganka Gakkai Zasshi; 1975 Mar; 79(3):172-6. PubMed ID: 1171606
    [No Abstract]   [Full Text] [Related]  

  • 13. Further studies on the identification of the subcomponents of the first component of complement after affinity chromatography of human serum on IgG-sepharose.
    Taylor PA; Fink S; Bing DH; Painter RH
    J Immunol; 1977 May; 118(5):1722-7. PubMed ID: 858917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative binding of a complement component to antigen-antibody complexes. III. Complexes containing IgM antibodies.
    Kuo CY; Thompson JJ; Hoffmann LG
    Z Immunitatsforsch Immunobiol; 1976 Sep; 152(2):151-66. PubMed ID: 960974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.
    Teshima H; Wanebo H; Pinsky C; Day NK
    J Clin Invest; 1977 Jun; 59(6):1134-42. PubMed ID: 325016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure and activation of the early components of complement.
    Porter RR
    Fed Proc; 1977 Aug; 36(9):2191-6. PubMed ID: 328305
    [No Abstract]   [Full Text] [Related]  

  • 18. Ultracentifuge studies of the binding of IgG of different subclasses to the Clq subunit of the first component of complement.
    Schumaker VN; Calcott MA; Spiegelberg HL; Müller-Eberhard HJ
    Biochemistry; 1976 Nov; 15(23):5175-81. PubMed ID: 990273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venom of the ant Pseudomyrmex sp.: further characterization of two factors that affect human complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1977 Nov; 119(5):1690-9. PubMed ID: 410881
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemistry of complement.
    Porter RR
    Ric Clin Lab; 1977; 7(3):191-7. PubMed ID: 605337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.